CRIS Current Research Information System

SABATTINI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.421
AS - Asia 8.421
NA - Nord America 8.273
SA - Sud America 588
Continente sconosciuto - Info sul continente non disponibili 449
AF - Africa 446
OC - Oceania 53
Totale 28.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.037
IT - Italia 6.214
CN - Cina 2.213
SG - Singapore 2.183
VN - Vietnam 2.075
GB - Regno Unito 918
DE - Germania 601
SE - Svezia 552
HK - Hong Kong 532
FR - Francia 439
BR - Brasile 415
NL - Olanda 342
IN - India 333
KR - Corea 240
RU - Federazione Russa 238
BD - Bangladesh 225
JP - Giappone 185
FI - Finlandia 171
IE - Irlanda 164
UA - Ucraina 135
ZA - Sudafrica 127
CH - Svizzera 126
CA - Canada 101
SC - Seychelles 97
TG - Togo 88
CI - Costa d'Avorio 87
MX - Messico 86
BG - Bulgaria 80
ES - Italia 66
ID - Indonesia 64
AR - Argentina 63
PH - Filippine 51
EE - Estonia 49
PL - Polonia 49
AT - Austria 46
TW - Taiwan 43
AU - Australia 42
BE - Belgio 41
PT - Portogallo 40
IQ - Iraq 37
TH - Thailandia 37
JO - Giordania 36
CL - Cile 34
PK - Pakistan 34
GR - Grecia 32
EC - Ecuador 27
TR - Turchia 27
RO - Romania 23
LT - Lituania 21
CO - Colombia 20
SA - Arabia Saudita 16
UZ - Uzbekistan 15
HR - Croazia 13
JM - Giamaica 13
PE - Perù 12
SI - Slovenia 12
HU - Ungheria 11
NZ - Nuova Zelanda 11
MY - Malesia 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 8
KZ - Kazakistan 8
DK - Danimarca 7
MA - Marocco 7
NG - Nigeria 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
GE - Georgia 6
IL - Israele 6
PY - Paraguay 6
TN - Tunisia 6
DZ - Algeria 5
GT - Guatemala 5
IR - Iran 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
ET - Etiopia 4
HN - Honduras 4
KE - Kenya 4
LB - Libano 4
SM - San Marino 4
AF - Afghanistan, Repubblica islamica di 3
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KN - Saint Kitts e Nevis 3
OM - Oman 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BS - Bahamas 2
GH - Ghana 2
MZ - Mozambico 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
SV - El Salvador 2
Totale 28.177
Salva come PNG Salva come JPEG
Città #
Singapore 1.494
Ashburn 906
Southend 680
Milan 596
San Jose 559
Hong Kong 509
Ho Chi Minh City 488
Chandler 476
Fairfield 438
Hefei 423
Rome 408
Santa Clara 401
Hanoi 367
Bologna 365
Dong Ket 347
Ann Arbor 286
Beijing 252
Council Bluffs 225
Seattle 212
Woodbridge 212
Wilmington 207
Princeton 205
Seoul 195
Dallas 191
Houston 191
New York 176
Boardman 169
Los Angeles 166
Dublin 164
Cambridge 156
Turin 148
Florence 145
Helsinki 129
Lauterbourg 115
Naples 112
Tokyo 107
Frankfurt am Main 94
Lomé 88
Abidjan 86
Nanjing 80
Westminster 80
Sofia 77
Genoa 76
São Paulo 74
Padova 73
Buffalo 68
Guangzhou 66
Berlin 65
Brescia 58
Zurich 57
Orem 56
Da Nang 55
Palermo 55
Haiphong 54
Jacksonville 52
Jinan 52
Redondo Beach 52
Bari 46
Shanghai 45
Shenyang 45
Medford 44
Johannesburg 43
Phoenix 42
Redmond 42
Redwood City 40
Bengaluru 38
Modena 38
Parma 38
San Diego 38
Atlanta 37
Brussels 37
London 37
Verona 37
Dearborn 36
Amman 35
Changsha 35
San Francisco 34
Jakarta 33
Saint Petersburg 33
Munich 32
Ancona 31
Nuremberg 31
Brooklyn 30
Des Moines 30
Tianjin 30
Hebei 29
Hyderabad 29
Warsaw 29
Amsterdam 27
Cagliari 27
Catania 27
Denver 27
Montreal 27
Lappeenranta 26
Messina 26
Monza 26
Paris 26
Hải Dương 25
Cesena 24
Hangzhou 24
Totale 15.074
Salva come PNG Salva come JPEG
Nome #
Attività antitumorale di un nuovo farmaco in due casi di linfoma cutaneo felino non responsivi a lomustina 1.552
Indicatori istopatologici di prognosi nel mastocitoma cutaneo e viscerale del gatto 1.366
Aspetto citologico, grado istologico, margini chirurgici e immunoistochimica del mastocitoma canino: in aiuto al clinico 1.113
Grading citologico del mastocitoma cutaneo del cane 801
Istologia, immunoistochimica e c-Kit nel mastocitoma felino: quanto servono al clinico? 666
Feline large granular lymphocyte lymphoma: An Italian Society of Veterinary Oncology (SIONCOV) retrospective study 434
The 2-tier grading system identifies canine cutaneous and/or subcutaneous mast cell tumors with aggressive biological behavior regardless of growth model 397
SIONCOV guidelines for diagnosis, staging, and treatment of feline intestinal lymphoma 396
Comparison between May-Grünwald-Giemsa and rapid cytological stains in fine-needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications 341
Emangiosarcoma: aspetti istopatologici e marker diagnostici 327
Linee guida SIONCOV 2023 per diagnosi, stadiazione e trattamento del carcinoma uroteliale di vescica e uretra del cane 291
Intraoperative methylene blue staining is effective as a single mapping technique in the identification of sentinel lymph nodes in dogs with low‐grade mast cell tumours 281
Canine Splenic Nodular Lymphoid Lesions: Immunophenotyping, Proliferative Activity, and Clonality Assessment 266
Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision 257
Comparison between May Grünwald-Giemsa and rapid stains in fine-needle aspirates of canine mast cell tumor: diagnostic and prognostic implications 253
Cytological differentiation between benign and malignant perianal gland proliferative lesions in dogs: a preliminary study 248
Environmental risk factors for the development of oral squamous cell carcinoma in cats 243
Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa 242
Papillomavirus associated malignancies in dogs and cats 241
Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery 236
Comparative Assessment of the Accuracy of Cytological and Histologic Biopsies in the Diagnosis of Canine Bone Lesions 230
Expression of cannabinoid and cannabinoid-related receptors in the oral mucosa of healthy cats and cats with chronic gingivostomatitis 229
A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma 224
An Evolutionary Cancer Epigenetic Approach Revealed DNA Hypermethylation of Ultra-Conserved Non-Coding Elements in Squamous Cell Carcinoma of Different Mammalian Species 222
Assessment of PDGFRβ promoter methylation in canine osteosarcoma using methylation-sensitive high-resolution melting analysis 222
Analysis of DNA methylation and TP53 mutational status for differentiating feline oral squamous cell carcinoma from non-neoplastic mucosa: A preliminary study 221
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy 214
A retrospective Italian Society of Veterinary Oncology (SIONCOV) study of 56 cats with appendicular osteosarcoma 213
Mastociti in circolo: semplici spettatori o partecipanti attivi? Controversie, diagnosi e prognosi della mastocitosi/mastocitemia felina 212
Comparison between May Grünwald-Giemsa and rapid stains in fine-needle aspirates of canine mast cell tumours: diagnostic and prognostic implications. 212
Ultrasonographic honeycomb pattern of the spleen in cats: correlation with pathological diagnosis in 33 cases 211
SIONCOV 2022 guidelines for staging canine cutaneous and subcutaneous mast cell tumors 209
A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors 208
Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014) 205
Longitudinal lymph node step-sectioning for the identification of metastatic disease in canine mast cell tumor 204
Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma 202
Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: An Italian Society of Veterinary Oncology study 202
EGFR expression is predictive of a poor prognosis in feline cutaneous squamous cell carcinoma. 201
Periarticular histiocytic sarcoma with heart metastasis in a cat 200
Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers 197
Adjuvant dose-intense versus metronomic chemotherapy for dogs with metastatic splenic hemangiosarcoma: a multi-institutional retrospective study. 196
Subcutaneous mast cell tumours: A prospective multi-institutional clinicopathological and prognostic study of 43 dogs 194
Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma 194
Comparison of definitive-intent finely fractionated and palliative-intent coarsely fractionated radiotherapy as adjuvant treatment of feline microscopic injection-site sarcoma 194
Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes 192
Histologic grade has a higher-weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes 188
Prognostic value of peripheral blood and bone marrow infiltration assessed by flow cytometry in dogs with de novo nodal peripheral T-cell lymphoma receiving alkylating-rich chemotherapy 185
Enhanced therapeutic effect of APAVAC vaccine in combination with dose-intense chemotherapy in dogs with clinically-advanced multicentric indolent B-cell lymphoma. 184
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain 182
A Retrospective Clinico-Pathologic Study of 35 Dogs with Urethral Transitional Cell Carcinoma Undergoing Treatment 179
A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy 179
Prognostic Value of Histologic and Immunohistochemical Features in Feline Cutaneous Mast Cell Tumors 179
Grading Cutaneous Mast Cell Tumors in Cats 178
Clinical Features and Outcome of 79 Dogs With Digital Squamous Cell Carcinoma Undergoing Treatment: A SIONCOV Observational Study 178
Role of CT in the Staging of Colorectal Tumors: A Preliminary Study on 10 Dogs 176
Reclassification of 21 presumptive canine peripheral nerve sheath tumors (pnst) using a literature-based immunohistochemical panel 176
Treatment of oral squamous cell carcinoma in a horse by surgical debulking followed by metronomic chemotherapy 173
Clinical relevance of simultaneous histopathological grading of canine cutaneous mast cell tumors at first presentation: a retrospective study on 386 cases. 173
Airway Remodeling in Feline Lungs 173
Metastatic Adenocarcinoma of Unknown Primary Origin Presenting with Severe Lumbar Neuropathic Pain in a Dog 172
P16 immunostaining of canine squamous cell carcinomas is not associated with papillomaviral DNA 172
Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy 172
Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study 171
Evaluation of Ki-67 expression in feline non-ocular melanocytic tumours 170
Clinicopathologic features and biologic behavior of canine splenic nodules with stromal, histiocytic and lymphoid components 169
Comparison of sonographic and CT findings for the identification of renal nodules in dogs and cats 168
COMPARISONS AMONG COMPUTED TOMOGRAPHIC FEATURES OF ADIPOSE MASSES IN DOGS AND CATS 164
Histopathological findings and proliferative activity of canine sebaceous gland tumours with a predominant reserve cell population 161
Chemo-switch improves outcome in surgically-removed, biologically aggressive canine hemangiosarcoma. 161
EGFR Expression is Predictive of Poor Prognosis in Feline Cutaneous Squamous Cell Carcinoma 160
Esperienze cliniche ed anatomopatologiche sulla c.d. Pancitopenia Neonatale del bovino. Nota preliminare 160
ASSESSMENT OF EGFR AND HER-2 EXPRESSION AND ERAS-STATUS IN CANINE GASTRIC TUMOURS 160
Validation of oral brushing as a non-invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis 160
Prognostic Significance of Kit Receptor Tyrosine Kinase Dysregulations in Feline Cutaneous Mast Cell Tumors 159
Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature 159
Brain Metastases From Solid Cancers in 58 Dogs 159
Mesenchymal stroma drives axonogenesis and nerve-induced aggressiveness in osteosarcoma 156
Dose and Duration of Upfront Steroid Administration Have no Prognostic Impact in Dogs With Multicentric Diffuse Large B-Cell Lymphoma 155
Immunohistochemical characterization of therapeutic targets in canine bladder cancer 155
Immunohistochemical prognosticators in feline cutaneous and visceral mast cell tumors. 155
EGFR expression and air pollution carcinogenesis in canine primary lung tumours 154
EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model? 154
Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the UBo pTNM System 153
SIONCOV 2022 guidelines for the treatment and histopathologic diagnosis of canine cutaneous and subcutaneous mast cell tumors 153
Ultrasonographic features of intestinal lipogranulomatous lymphangitis in 10 dogs 152
A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy 152
Feline large granular lymphocyte lymphoma: an Italian Society of Veterinary Oncology (SIONCOV) retrospective study. 151
Expression Profile of Twelve Transcripts as a Supporting Tool for the Molecular Characterization of Canine Cutaneous Mast Cell Tumors at Diagnosis: Association with Histological Grading and Clinical Staging 150
EGFR overexpression in canine primary lung cancer: pathogenetic implications and impact on survival 150
COMPARISON OF A HYPOFRACTIONATED VERSUS A FULL-COURSE RADIOTHERAPY PROTOCOL FOR THE TREATMENT OF MICROSCOPIC CUTANEOUS MAST CELL TUMOURS IN DOGS. 150
Prognosis following surgical excision in canine and feline malignant skin tumors: the role of the histological evaluation of margins. 149
Immunohistochemical Analysis of Canine Haemangioma and Haemangiosarcoma 147
Combination of radiation therapy and a selective COX-2 inhibitor (firocoxib) in the treatment of canine nasal carcinomas 147
Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours 147
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi-institutional retrospective study 146
CLINICAL OUTCOME OF DOGS WITH UROTHELIAL CARCINOMA TREATED WITH DOSE-INTENSE CHEMOTHERAPY VERSUS RADIO-CHEMOTHERAPY: A SINGLE-INSTITUTIONAL PROSPECTIVE UNBLINDED STUDY. 145
A phase 2, single-arm, open-label clinical trial on adjuvant active immunotherapy in dogs with appendicular osteosarcoma undergoing amputation and chemotherapy 143
Histological grading of canine mast cell tumor: is two better than three? 142
Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma 141
Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide 140
Totale 24.046
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.863 0 94 90 190 243 168 73 139 105 118 351 292
2022/20232.707 248 362 158 282 162 282 110 174 415 119 264 131
2023/20241.840 109 193 111 125 142 221 151 121 76 198 192 201
2024/20254.750 361 582 365 371 639 269 428 230 205 324 301 675
2025/202610.899 728 1.225 883 730 1.089 547 1.051 539 2.035 813 685 574
2026/20271.261 646 615 0 0 0 0 0 0 0 0 0 0
Totale 28.651